Platform Comparison
How Ambrosia Compares
1,600+ real biopharma deals. 14 calculation engines. 12 therapeutic areas. See how Ambrosia stacks up against the legacy platforms.
Ambrosia vs DealForma
Deal comps database vs integrated deal intelligence
DealForma is a well-established licensing deal comps database used across BD. Solidus integrates deal benchmarks with 21 analytical engines — rNPV, Monte Carlo, AI deal memos, and partner matching — so you go from data to decision in one platform.
DealForma strengths
Ambrosia edge
Ambrosia vs EvaluatePharma
Consensus forecasts vs deal-specific benchmarking
EvaluatePharma excels at consensus revenue forecasts and pipeline analytics. Solidus focuses on deal-specific mechanics — upfronts, milestones, royalties, and real-time comparable deal intelligence.
EvaluatePharma strengths
Ambrosia edge
Ambrosia vs S&P Capital IQ
Broad financial data vs deal-specific depth
Capital IQ covers M&A, equity, and credit data across all industries. Solidus goes deep on biopharma licensing deal terms — the economics that drive BD decisions.
S&P Capital IQ strengths
Ambrosia edge
Ambrosia vs Clarivate Cortellis
Enterprise data platform vs deal modeling workbench
Cortellis provides deep pipeline, regulatory, and patent intelligence with 15,500+ deal records. Solidus delivers the deal economics and modeling layer — 21 engines for valuation, competitive dynamics, and partner matching.
Clarivate Cortellis strengths
Ambrosia edge
Ready to see the difference? Try Ambrosia with your own deal parameters.